» Articles » PMID: 28415772

Endoscopic Therapy for Patients with Pancreaticobiliary Maljunction: a Follow-up Study

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Apr 19
PMID 28415772
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Data on the experience of endoscopic retrograde cholangiopancreatography (ERCP) in the management of pancreaticobiliary maljunction (PBM) is limited.

Methods: A retrospective review of patients with PBM who underwent therapeutic ERCP at our endoscopy center between January 2008 and January 2016 was performed. Demographic, clinical, radiological and endoscopic data was documented. Patients who underwent sphincterotomy were divided into dilated group and undilated group based on their common channel diameter.

Results: Sixty-three PBM patients underwent 74 ERCP procedures. The technical success rate was 97.3%. ERCP therapy significantly decreased the levels of elevated liver enzymes and bilirubin. After an average of 27 months follow-up, 7 patients (11.1%) were lost. The overall effective rate of ERCP therapy was 60.7% (34/56). Decline in severity and frequency of abdominal pain was significant. Procedure-related complications were observed in 5 (6.8%) cases. Between the dilated group and undilated group, no significant difference was observed in effective rate, adverse events and follow-up results.

Conclusions: ERCP can serve as a transitional step to stabilize PBM patients before definitive surgery. PBM patients with undilated common channel could benefit from sphincterotomy as well as those with dilated common channel.

Citing Articles

Common bile duct stump stones and recurrent acute pancreatitis after Roux-en-Y choledochojejunostomy in a child: A case report.

Li J, Xie M, Wei J, Yang C, Chen G, Li L World J Gastrointest Surg. 2025; 17(2):102105.

PMID: 40061985 PMC: 11885987. DOI: 10.4240/wjgs.v17.i2.102105.


Endoscopic retrograde cholangiopancreatography in children with pediatric congenital biliary dilatation associated with pancreatobiliary maljunction: experience from a tertiary center.

Rollo G, Balassone V, Faraci S, Torroni F, DallOglio L, De Angelis P Front Pediatr. 2025; 12():1484375.

PMID: 39834498 PMC: 11743432. DOI: 10.3389/fped.2024.1484375.


Diagnosis and Treatment of Choledochal Cysts: A Comprehensive Review with a Focus on Choledochocele.

Ciccioli C, Mazza S, Sorge A, Torello Viera F, Mauro A, Vanoli A Dig Dis Sci. 2024; 70(1):39-48.

PMID: 39589463 DOI: 10.1007/s10620-024-08708-y.


Recurrent Acute Pancreatitis in the Setting of Abnormal Pancreaticobiliary Junction.

Antonios K, Shah N, McGorisk T Cureus. 2023; 15(10):e47029.

PMID: 37965410 PMC: 10642712. DOI: 10.7759/cureus.47029.


A light in the dark: Peroral cholangioscopy provides a new strategy for difficult cannulation in pancreaticobiliary maljunction.

Zhang W, Zhong N, Ji R Endoscopy. 2023; 55(10):968-969.

PMID: 37757792 PMC: 10533214. DOI: 10.1055/a-2154-3461.


References
1.
Christoforidis E, Goulimaris I, Kanellos I, Tsalis K, Demetriades C, Betsis D . Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors. Endoscopy. 2002; 34(4):286-92. DOI: 10.1055/s-2002-23630. View

2.
Rocca R, Castellino F, Daperno M, Masoero G, Sostegni R, Ercole E . Therapeutic ERCP in paediatric patients. Dig Liver Dis. 2005; 37(5):357-62. DOI: 10.1016/j.dld.2004.09.030. View

3.
Kamisawa T, Ando H, Suyama M, Shimada M, Morine Y, Shimada H . Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol. 2012; 47(7):731-59. DOI: 10.1007/s00535-012-0611-2. View

4.
He Q, Xu T, Wang J, Li Y, Wang L, Zou X . Risk factors for post-ERCP pancreatitis and hyperamylasemia: A retrospective single-center study. J Dig Dis. 2015; 16(8):471-8. DOI: 10.1111/1751-2980.12258. View

5.
Cotton P, Garrow D, Gallagher J, Romagnuolo J . Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009; 70(1):80-8. DOI: 10.1016/j.gie.2008.10.039. View